01.21.26 -- Biology, Specificity, And The Rules Of RNA Business Strategy In 2026

Look behind LNP formulation development, from ionizable lipids to scalable manufacturing through case studies, screening strategies, and flexible approaches for advancing next-generation therapeutics.

Hear how engineered enzymes improve mRNA synthesis by reducing double-stranded RNA and lowering input costs. These advancements ensure high purity and integrity for complex therapeutic templates.

Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation, helping companies move forward with greater confidence.

A successful large-scale public health emergency response requires adaptable manufacturing capabilities, an experienced workforce, and effective private-public partnerships.

Master the essential strategies for cost-effective and robust mRNA capping at industrial scale. Learn how to evaluate new materials and optimize your synthesis process for maximum efficiency and yield.

Gain a clearer view of the scientific, operational, and regulatory forces propelling the next wave of oncology innovation, and what they mean for sponsors advancing cutting-edge cancer therapies.

Here, we provide a detailed description of assays for sequence identification and LNP composition in mRNA-LNP products that support the development of safe and effective mRNA therapies.